MUSK-targeting agonist antibody is protective against experimental congenital myasthenia July 20, 2021
YishengBio cleared in UAE to conduct phase I study of PIKA recombinant COVID-19 vaccine July 20, 2021
U.S. phase II trial explores use of Velexbru in primary central nervous system lymphoma July 19, 2021
Phase II/III trial studies SHR-1701 with BP-102 and XELOX in first-line metastatic colorectal cancer July 19, 2021
Clarity recruits patients with prostate cancer to evaluate PET imaging with [64Cu]SAR-bisPSMA July 19, 2021
RSS